Bet on Earnings, No...
Health Care: Drugs
Ampio Pharmaceuticals Inc. (AMPE: AMEX)
$6.08 0.12 | 2.01%
06/18/13 - 04:03 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 18.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 18.70 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 8.60 | 12.50 |
| Beta | 1.75 | 0.58 | 0.98 |
| Price to Sales (TTM) | 4,614.19 | 3.15 | 1.42 |
| Price to Book (MRQ) | 10.03 | 3.87 | 2.41 |
| Price to Tangible Book (MRQ) | 10.39 | 56.56 | 5.08 |
| Price to Cash Flow (TTM) | -17.90 | 12.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -21.30 | 40.40 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 3.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 3.90 | 2.30 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 2.79 | 2.61 |
| Payout Ratio (TTM) | 0.00 | 62.00 | 37.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 0.00 | -8.70 | -0.90 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 166.70 | -3.50 | 2.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | n.a. | 2.84 | 3.97 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | -0.80 | 18.70 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | -0.80 | 18.70 |
| EPS - 5 Yr Growth Rate (%) | n.a. | -1.24 | 8.27 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | -10.61 | 4.03 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 9.60 | 1.30 | 1.10 |
| Current Ratio (MRQ) | 9.80 | 1.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.38 | 0.73 |
| Total Debt to Equity (MRQ) | 0.00 | 0.49 | 0.86 |
| Interest Coverage (TTM) | n.a. | 13.10 | 6.40 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 76.50 | 47.50 |
| Gross Margin - 5 Yr Avg | n.a. | 77.70 | 46.90 |
| EBITD Margin (TTM) | n.a. | 30.60 | 19.40 |
| EBITD - 5 Yr Avg | -43,257.32 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 19.70 | 11.30 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 22.10 | 10.10 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.00 | 0.17 | 0.08 |
| Net Profit Margin - 5 Yr Avg | n.a. | 17.40 | 7.00 |
| Return on Assets (TTM) | -50.80 | 9.90 | 3.10 |
| Return on Assets - 5 Yr Avg | -82.50 | 8.50 | 2.50 |
| Return on Investment (TTM) | -56.00 | 15.90 | 8.20 |
| Return on Investment - 5 Yr Avg | -101.00 | 13.60 | 6.60 |
| Efficiency | |||
| Revenue/Employee (TTM) | 3,846.00 | n.a. | n.a. |
| Net Income/Employee (TTM) | -997,346.00 | n.a. | n.a. |
| Receivable Turnover (TTM) | n.a. | 5.00 | 7.90 |
| Inventory Turnover (TTM) | n.a. | 2.30 | 7.70 |
| Asset Turnover (TTM) | 0.00 | 0.60 | 0.40 |
Portfolios with AMPE
- Portfolio NameUser Type
- UserFlying Monkey King's Actuals
- ContributorStocks Under-$10 Setting Up...
- UserFirst Try
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest AMPE Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Ampio's Eye Drug Trial Design Won't Pass FDA Muster 04.02.13 | 09:04 am
- 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- A Biotech Short Seller Responds To Critics 07.17.12 | 08:07 am
- Ampio Insiders, Aided by PR Blitz, Soon Free to Sell Millions of Shares 07.02.12 | 01:07 pm
- Biotech Stock Mailbag: Osiris, Arena, Ampio 06.22.12 | 06:06 am
- Ampio Spins A Tale of Curing Blindness 06.11.12 | 03:06 pm
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- 6 Stocks Under $10 Moving Higher 12.14.11 | 01:12 pm
Press Releases for AMPE
- Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog - PR Newswire 06.07.13 | 08:06 am
- Ampio Pharmaceuticals To List On The NYSE MKT - PR Newswire 06.06.13 | 08:06 am
- Ampio Pharmaceuticals Announces Participation At The UBS Global Healthcare Conference - PR Newswire 05.13.13 | 08:05 am
- Ampio Pharmaceuticals Completes Enrollment In Run-In SPRING Study Of Ampion In Osteoarthritis Of The Knee - PR Newswire 04.25.13 | 08:04 am
- Ampio Receives FDA Clearance To Initiate Clinical Trial Of Ampionâ¿¢ For The Treatment Of Osteoarthritis Of The Knee: Patient Treatments Have Begun. - PR Newswire 04.02.13 | 04:04 am
- Ampio Receives FDA Acceptance Of Its Patient Outcome For Premature Ejaculation (POPE) Questionnaire, Paving The Way For Its US Pivotal Trial On Zertaneâ¿¢ - PR Newswire 03.11.13 | 04:03 am
- Ampio Pharmaceuticals Initiates Clinical Trial Of Optinaâ¿¢ In Diabetic Macular Edema (DME): First Patient Dosed - PR Newswire 02.27.13 | 04:02 am
- Ampio Pharmaceuticals Modifies Ampionâ¿¢ IND For Osteoarthritis Of The Knee To Include A Dose Escalation Run-In Study And Prepares To Launch Pivotal Clinical Trial - PR Newswire 02.25.13 | 04:02 am
- Ampio Forms Luoxis Diagnostics To Commercialize ORP Technology - PR Newswire 02.11.13 | 04:02 am
- Ampio Pharmaceuticals Announces Participation At Upcoming Investor Conference - PR Newswire 01.22.13 | 04:01 am
Partner Headlines for AMPE
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- Ultimate Market Recap: Barclays Chairman Bows Out, ATPG Looking Slick - Wall St. Cheat Sheet 07.02.12 | 10:07 am
- Morning Market Movers - Benzinga 07.02.12 | 09:07 am
- Arena Pharma FADES Below $10 and 4 High Demand Stocks ATTRACTING Eyes - Wall St. Cheat Sheet 07.02.12 | 02:07 am
- Weekly Market Wrap: Stocks RALLY, Gold SPARKLES, Apple's New Products REVEALED - Wall St. Cheat Sheet 06.17.12 | 12:06 pm
- Company News for June 12, 2012 - Corporate Summary - Zacks 06.12.12 | 10:06 am
- These 5 Small Cap Stocks Are Up Better Than 10% Today - Benzinga 06.11.12 | 01:06 pm
- 4 Contrarian Stock Climbers in Trading Action as Centene Falls Hard - Wall St. Cheat Sheet 06.11.12 | 01:06 pm
- Market Wrap: Gold GLITTERS as Apple's Innovation is Analyzed - Wall St. Cheat Sheet 06.11.12 | 10:06 am
